Moderna
Moderna is a biopharmaceutical company based in Cambridge, Mass. Most known for its Covid-19 vaccine, the firm has more than 40 treatment or vaccine candidates in various stages of research or development aimed for use against influenza, Zika, HIV and Epstein–Barr.
Moderna specializes in RNA therapeutics, primarily mRNA vaccines. The name comes from a molecule called messenger RNA (mRNA) that carries instructions for proteins to generate an immune response.
Latest
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
STAT Plus: HHS leader to vaccine makers: Set ‘reasonable’ prices for your next round of Covid-19 vaccines
STAT Plus: At a defunct power station, the U.K. and Moderna celebrate a partnership meant to be an engine for science
Tired of ‘dead end’ approach, herpes patients mobilize to demand government action
STAT Plus: Moderna-Merck mRNA cancer vaccine shows promise in combination with melanoma drug
Listen: How the legal battle over abortion could thwart research, plus: the FDA ‘bully pulpit’ and Moderna’s future
